Drugs / laduviglusib
laduviglusib
also known as
CHIR 99021 · CHIR-911 · CHR-00921 · CT 99021 · FX03 · GSK-3 INHIBITOR XVI · KIN001-157 · LADUVIGLUSIB (CHIR-99021)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03616223 | Jul → Dec 2018 | sensorineural hearing loss disorder | Frequency Therapeutics | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | laduviglusib | “Intratympanic injection of FX-322 consists of laduviglusib and sodium valproate” NCT03616223 ↗ |
| Known as | CHIR 99021 | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | CHIR-911 | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | CHR-00921 | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | CT 99021 | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | FX03 | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | GSK-3 INHIBITOR XVI | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | KIN001-157 | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Known as | LADUVIGLUSIB (CHIR-99021) | ChEMBL registry synonym — accepted as the source's own label CHEMBL412142 ↗ |
| Modality | Small molecule | — CHEMBL412142 ↗ |